Publication | Open Access
2018 ASPHO ABSTRACTS
36
Citations
0
References
2018
Year
Background: Survival for SR (age 1-9.99 yrs. and initial white blood cell count <50,000/microliter) B-ALL patients with DS has improved over time through enrollment on therapeutic trials and enhanced supportive care.